When used at the same time, serum thyroglobulin (Tg) levels measurement and 131I whole body scanning offer best possibilities in the patients’ follow-up.1 Serum Tg is a tumour marker and radioiodine scans localize tumour sites. The gene discussed is TG; the disease is neoplasm.